Print
Email
Biomarin Pharmaceutical Inc. has a market cap of $3.73 billion; its shares were traded at around $33.38 with and P/S ratio of 9.9.
This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.
CEO Recent Trades:
- CEO Jean Jacques Bienaime sold 1,000 shares of BMRN stock on 09/28/2011 at the average price of 32. Jean Jacques Bienaime owns at least 126,093 shares after this. The price of the stock has increased by 4.31% since.
- CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 08/30/2011 at the average price of 29.01. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 15.06% since.
- CEO Jean Jacques Bienaime sold 2,000 shares of BMRN stock on 08/19/2011 at the average price of 26.75. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 24.79% since.
- CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 08/12/2011 at the average price of 27.1. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 23.17% since.
- CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 08/02/2011 at the average price of 30.27. Jean Jacques Bienaime owns at least 127,093 shares after this. The price of the stock has increased by 10.27% since.
CFO Recent Trades:
- SVP, CFO Jeffrey H Cooper sold 18,379 shares of BMRN stock on 09/28/2011 at the average price of 32. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 4.31% since.
- SVP, CFO Jeffrey H Cooper sold 2,500 shares of BMRN stock on 09/01/2011 at the average price of 29.41. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 13.5% since.
- SVP, CFO Jeffrey H Cooper sold 18,036 shares of BMRN stock on 08/02/2011 at the average price of 30.47. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 9.55% since.
- SVP, CFO Jeffrey H Cooper sold 18,378 shares of BMRN stock on 07/14/2011 at the average price of 30. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 11.27% since.
- SVP, CFO Jeffrey H Cooper sold 2,500 shares of BMRN stock on 07/01/2011 at the average price of 27.5. Jeffrey H Cooper owns at least 39,876 shares after this. The price of the stock has increased by 21.38% since.
This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.
Directors and Officers Recent Trades:
- EVP, Chief Medical Officer Henry J Fuchs sold 2,500 shares of BMRN stock on 10/03/2011 at the average price of 31. Henry J Fuchs owns at least 36,455 shares after this. The price of the stock has increased by 7.68% since.
- VP, Human Resources Mark Wood sold 1,854 shares of BMRN stock on 09/22/2011 at the average price of 29.92. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 11.56% since.
- VP, Human Resources Mark Wood sold 834 shares of BMRN stock on 08/31/2011 at the average price of 30. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 11.27% since.
- VP, Human Resources Mark Wood sold 1,020 shares of BMRN stock on 08/22/2011 at the average price of 27.03. Mark Wood owns at least 20,634 shares after this. The price of the stock has increased by 23.49% since.
- EVP, Technical Operations Robert Baffi sold 18,687 shares of BMRN stock on 08/02/2011 at the average price of 30.55. Robert Baffi owns at least 83,160 shares after this. The price of the stock has increased by 9.26% since.
For the complete insider trading history of BMRN, click here.
Subscribe RSS
